WG Critical Care

TENIPOSIDE

Manufacturer:

WG Critical Care

Teniposide HCPCS:

Q2017

HCPCS Code Descriptor:

Injection, teniposide, 50 mg

Category:

Q Code

Teniposide NDCs:

44567-0507-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

44567-0507-01

About Teniposide:

TENIPOSIDE is an Oncology drug manufactured by WG Critical Care and administered via the Intravenous route of administration. The Q Code: Q2017 is aligned to the drug TENIPOSIDE.

ACCESS PRICING AND MORE BY REGISTERING

Q2017 Added Date:

July 1, 2000

Q2017 Effective Date:

January 1, 2023

Q2017 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Teniposide billing and coding information.
Our team did not identify a source for Teniposide patient assistance information. Please reach out to our team if you feel that this is a mistake.
TENIPOSIDE prescribing information can be found at the link below:
Information regarding TENIPOSIDE’s side effects can be found at MedlinePlus